// App-Quantinova.ai

10286 : Benefit of High-Dose Atorvastatin in Patients With Acute Coronary Syndromes After Recent Influenza-like Illness: Results From the PROVE IT-TIMI 22 Trial

Researchers

Presenter

  • Deepak L. Bhatt

Principal Investigators

  • Elaine B Hoffman

  • Christopher P Cannon

Medical Centers

  • Brigham & Women's Hospital, Boston, MA

  • Medicine, University of Toronto, Women s College Hospital, Toronto, Canada

  • VA Boston Healthcare System and Brigham and Women's Hosp, Boston, MA

Locations

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Acute Coronary Syndromes

  • Coronary Artery Disease

  • Systemic inflammation

  • Influenza

  • Stroke

Biomarkers

  • High sensitivity C-reactive protein

Drug/Treatment

  • Atorvastatin

  • Gatifloxacin

  • Pravastatin sodium

Outcome

  • N/A

Study Design

  • randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved